BGG463 (K03859) is an orally active type II CDK2 inhibitor
In Vitro
BGG463 potently inhibits T315I BCR–ABL autophosphorylation and shows good oral efficacy in mouse models of CML. MCE has not independently confirmed the accuracy of these methods. They are for reference only.